Sensei Biotherapeutics, Inc. SNSE 深 沪
等待开盘 04-02 09:30:00 美东时间
34.79
+3.270
+10.37%
华盛通- 最 高36.02
- 今 开31.70
- 成交量 6.79万股
- 最 低 31.70
- 昨 收 31.52
- 总市值 4662.84万
- 52周最高 36.76
- 市盈率 静 --
- 换手率 5.06%
- 52周最低 5.25
- 委 比 -92.31%
- 总股本 134.03万
- 历史最高 530.00
- 量 比 0.75
- 振 幅 13.71%
- 历史最低 5.00
- 每 手 1
- 风险率 7.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
BRIEF-Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update March 30 (Reuters) - Sensei Biotherapeutics Inc SNSE.O : SENSEI BIOTHERAPEUTICS REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Source text: ID:nBwjmfmya Further company coverag
03-30 20:01
Sensei Biotherapeutics Q4 EPS $(3.74) Beats $(4.11) Estimate
Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(3.74) per share which beat the analyst consensus estimate of $(4.11) by 9 percent. This is a 39.68 percent increase over losses of $(6.20) per share
03-30 19:50
Sensei Biotherapeutics GAAP EPS of -$16.72
Sensei Biotherapeutics press release (SNSE): FY GAAP EPS of -$16.72. Cash, cash equivalents and marketable securities were $21.2 million as of December 31, 2025 as compared to $41.3 million as of Dece...
03-30 19:37
Sensei Biotherapeutics FY25 net loss narrows 30% to $21.1 million
Sensei Biotherapeutics FY25 net loss narrows 30% to $21.1 million Sensei Biotherapeutics posted a net loss of $21.1 million. Operating loss narrowed to $22.3 million as operating expenses fell to $22.3 million. R&D expense dropped to $11 million due to reduced costs across personnel, facilities, lab
03-30 19:31
BRIEF-Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
BRIEF-Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) March 17 (Reuters) - Sensei Biotherapeutics Inc SNSE.O : SENSEI BIOTHERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nBw9sZpCla Further company coverage: SNSE.O (
03-17 18:17
Sensei Biotherapeutics grants employee stock option for 166,435 shares at USD 29.37
Sensei Biotherapeutics grants employee stock option for 166,435 shares at USD 29.37 Sensei Biotherapeutics said its board granted a new employee a stock option to purchase 166,435 common shares. The option has an exercise price of USD 29.37 per share. The award vests 25% on the first anniversary of
03-17 18:00
Sensei Biotherapeutics Grants 2.32M Inducement Stock Options to 17 New Employees
Sensei Biotherapeutics Grants 2.32M Inducement Stock Options to 17 New Employees Sensei Biotherapeutics granted stock options covering 2,319,893 shares to 17 newly hired employees, including an option for Chief Operating Officer Anand Parikh to purchase 1,239,305 shares. The options carry an exercis
02-25 19:00
Nasdaq Surges Over 1%; US Durable Goods Orders Fall In December
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gai...
02-19 01:59
Nasdaq Surges Over 1%; US Durable Goods Orders Fall In December
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gai...
02-19 01:59
Sensei Biotherapeutics Stock Soars 230% After Faeth Deal
SNSE up on acquisition of Faeth Therapeutics, $200M private placement, and addition of PIKTOR to pipeline targeting cancer.
02-19 01:09
